OPTEL GROUP has launched a new product line, Certa, designed specifically to help hospital and retail pharmacies comply with the requirements of the European Union Falsified Medicines Directive (EU FMD), which comes into effect on February 9, 2019.
Building upon OPTEL’s 28 years of expertise in vision, inspection and traceability, OPTEL offers pharmacies a product that enables them to meet immediate compliance needs, and also includes features intended to enhance their long-term strategic operations.
